APA (7th ed.) Citation

D, H., J, Z., J, S., N, Y., Q, L., J, Z., . . . J, Z. (2026). The impact of anti-phosphatidylserine/prothrombin antibodies on pregnancy outcomes in patients with unexplained recurrent implantation failure: A retrospective cohort study. Frontiers in immunology, 17, 1731905. https://doi.org/10.3389/fimmu.2026.1731905

Chicago Style (17th ed.) Citation

D, Han, Zhou J, Shi J, Yang N, Liu Q, Zhang J, Wang H, Wang Y, and Zhao J. "The Impact of Anti-phosphatidylserine/prothrombin Antibodies on Pregnancy Outcomes in Patients with Unexplained Recurrent Implantation Failure: A Retrospective Cohort Study." Frontiers in Immunology 17 (2026): 1731905. https://doi.org/10.3389/fimmu.2026.1731905.

MLA (9th ed.) Citation

D, Han, et al. "The Impact of Anti-phosphatidylserine/prothrombin Antibodies on Pregnancy Outcomes in Patients with Unexplained Recurrent Implantation Failure: A Retrospective Cohort Study." Frontiers in Immunology, vol. 17, 2026, p. 1731905, https://doi.org/10.3389/fimmu.2026.1731905.